Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Study of the Effect of Daily Treatment With MPC-7869 in Subjects With Dementia of the Alzheimer's Type

NCT00380276 is registered in ClinicalTrials.gov with Myrexis Inc. as lead sponsor.

NCT NCT00380276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00380276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Study of the Effect of Daily Treatment With MPC-7869 in Subjects With Dementia of the Alzheimer's Type
Lead sponsor
Myrexis Inc.
Phase
Phase 3
Overall status
Terminated
Start date
September 30, 2006
Completion date
December 31, 2008
Enrollment
1,000 (estimated)
Sites
90

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease